Looks like you may be right
Global competitor Equinox trades roughly on same multiples and its growth has been exceptional as well.
$1,842 million ebitda is expected FY17 , Enterprise value is around 32.6B
Equinox Enterprise Value/Ebitda is projected to be 17.7 times for FY17
NXT Enterprise Value/Ebitda is at 18 times if FY17 ebitda comes in at 50m or 19.6 times if ebitda comes in at 46m
NXT looks fully priced when compared to Equinox (nasdaq-eqix)
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
NXT
nextdc limited
Add to My Watchlist
0.66%
!
$14.25

Looks like you may be right Global competitor Equinox trades...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.25 |
Change
-0.095(0.66%) |
Mkt cap ! $9.129B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.23 | $21.02M | 1.469M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 315 | $14.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.25 | 1752 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 1930 | 14.260 |
16 | 2869 | 14.250 |
10 | 2603 | 14.240 |
16 | 4275 | 14.230 |
12 | 3626 | 14.220 |
Price($) | Vol. | No. |
---|---|---|
14.270 | 1086 | 11 |
14.280 | 3286 | 12 |
14.290 | 4519 | 14 |
14.300 | 3416 | 12 |
14.310 | 4797 | 9 |
Last trade - 14.41pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online